A new report from manufacturers’ organisation, EEF, and business advisory firm, BDO, has highlighted that strong performance by the UK’s manufacturing sector may be masking future concerns around future investment and trade.
Global specialty pharma company, Theramex, and private pharma company, Endoceutics, have entered into a definitive agreement for the exclusive licensing of Intrarosa (Prasterone) in Europe, Australia, Russia and the Ukraine.
Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Research (NIHR) show.
The US Food and Drug Administration (FDA) has issued a warning to consumers about criminals who are forging warning letters, as though they have been written by the agency, in efforts to target individuals who are trying to purchase medicines online
New research from The Center for Advancing Innovation (CAI) and PatSnap — a provider of R&D analytics — has revealed that the West is starting to lose its position as leaders in the Innovation Arms Race.
Here, we have a chat with Billy Amzal, PhD, X-Eng, MSc, MPA, who has been appointed as Certara’s senior vice president, decision and real-world data analytics.
Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter.
Swedish based pharmaceutical development company, Kancera, has announced that unique blockers (antagonists) of the Fractalkine system have been patented, laying the foundations for the development of additional drug candidates.
According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market.
The US Food and Drug Administration (FDA) has issued warnings to two Chinese drug manufacturers for violations of good manufacturing practice (GMP), according to a post from the Regulatory Affairs Professionals Society (RAPS).
After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain
